Cytarabine Injection, Solution
Product Images NDC 25021-229

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 25021-229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cyt0b 0000 01)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cyt0b 0000 02)

Package Label – Principal Display Panel – Vial Label (Cyt0b 0000 02)
This is a description of a pharmaceutical product with NDC code 25021-228-05. The product is an injection that contains Cytarabine with a strength of 100mg per 5ml. It comes in a single-dose vial that contains 20 mg of the drug per mL. The vial is suitable for intravenous, intrathecal, and subcutaneous use. The product has a code number of AP/DRUGS/03/2011 and dimensions of 5;2%%@352 S 131100140100 pl. The location of the company that produces the product is Schaumburg, IL 601, but the text does not provide any further details about it.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.